Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

[The performance of the automated immune chemiluminescent system "IMMULITE 2000XPi for the measurement of serum soluble IL-2 receptor in clinical samples].

Watanabe N, Nagatomo R, Okubo S, Yokota H, Masuda A, Ikeda H, Yatomi Y.

Rinsho Byori. 2012 May;60(5):422-8. Japanese.

PMID:
22774570
2.

[Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].

Shimomura Y, Tsurumi H, Sawada M, Yamada T, Hara T, Fukuno K, Goto H, Moriwaki H.

Rinsho Ketsueki. 1999 Aug;40(8):639-45. Japanese.

PMID:
10496038
3.

[Usefulness of the measurement of serum soluble IL-2 receptor alpha chain levels in clinical monitoring of non-Hodgkin lymphoma].

Setoyama Y, Imai J, Ishikawa T, Sakaida H, Takaori-Kondo A, Kawamata S, Uchiyama T.

Rinsho Byori. 1994 Aug;42(8):834-42. Japanese.

PMID:
7933620
4.

Prognostic value of serum IL-10 and soluble IL-2 receptor levels in aggressive non-Hodgkin's lymphoma.

Stasi R, Zinzani PL, Galieni P, Lauta VM, Damasio E, Dispensa E, Dammacco F, Papa G, Tura S.

Br J Haematol. 1994 Dec;88(4):770-7.

PMID:
7819101
5.
6.
7.

Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus.

Doganay S, Evereklioglu C, Er H, Türköz Y, Sevinç A, Mehmet N, Savli H.

Eye (Lond). 2002 Mar;16(2):163-70.

8.

Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer.

Hurteau JA, Woolas RP, Jacobs IJ, Oram DC, Kurman CC, Rubin LA, Nelson DL, Berchuck A, Bast RC Jr, Mills GB.

Cancer. 1995 Nov 1;76(9):1615-20.

9.

Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.

Naumnik W, Chyczewska E, Kovalchuk O, Tałałaj J, Izycki T, Panek B.

Rocz Akad Med Bialymst. 2004;49:246-51.

PMID:
15631351
10.

Use of serum soluble interleukin-2 receptor levels to monitor the progression of cutaneous T-cell lymphoma.

Vonderheid EC, Zhang Q, Lessin SR, Polansky M, Abrams JT, Bigler RD, Wasik MA.

J Am Acad Dermatol. 1998 Feb;38(2 Pt 1):207-20.

PMID:
9486676
11.

Clinical significance of the serum IL-2R level and Ga-67 scan findings in making a differential diagnosis between sarcoidosis and non-Hodgkin's lymphoma.

Kita T, Watanabe S, Yano F, Hayashi K, Yamamoto M, Iwasaki Y, Kosuda S.

Ann Nucl Med. 2007 Nov;21(9):499-503. Epub 2007 Nov 26.

PMID:
18030581
12.

Prognostic relevance of soluble interleukin-2 receptors in patients with ovarian tumors.

Gebauer G, Rieger M, Jäger W, Lang N.

Anticancer Res. 1999 Jul-Aug;19(4A):2509-11.

PMID:
10470184
13.

Significance of soluble interleukin-2 receptor levels for evaluation of the progression of adult T-cell leukemia.

Kamihira S, Atogami S, Sohda H, Momita S, Yamada Y, Tomonaga M.

Cancer. 1994 Jun 1;73(11):2753-8.

14.

[Serum soluble interleukin-2 receptor levels in patients with renal cell carcinoma: a comparison of values before and after surgery].

Tsukamoto S, Ishikawa S, Yamauchi A, Saitou S.

Hinyokika Kiyo. 2000 Oct;46(10):695-9. Japanese.

PMID:
11215193
15.

Thyroid function and thyroid autoimmunity independently modulate serum concentration of soluble interleukin 2 (IL-2) receptor (sIL-2R) in thyroid diseases.

Mariotti S, Caturegli P, Barbesino G, Marinò M, Del Prete GF, Chiovato L, Tonacchera M, De Carli M, Pinchera A.

Clin Endocrinol (Oxf). 1992 Nov;37(5):415-22.

PMID:
1486691
16.

The clinical significance of serum soluble interleukin 2 receptor (sIL-2R) concentration in lung cancer.

Naumnik W, Chyczewska E.

Folia Histochem Cytobiol. 2001;39 Suppl 2:185-6.

PMID:
11820599
17.
18.

[Clinical significance of soluble interleukin-2 receptor in multiple myeloma].

Akimoto Y, Ishiyama T, Ueno H, Hino K, Tomoyasu S, Tsuruoka N.

Rinsho Ketsueki. 1995 Nov;36(11):1247-51. Japanese.

PMID:
8691563
19.

Analysis of interleukin-2/interleukin-2 receptor system in advanced non-small-cell lung cancer.

De Vita F, Turitto G, di Grazia M, Frattolillo A, Catalano G.

Tumori. 1998 Jan-Feb;84(1):33-8.

PMID:
9619711
20.

Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.

Igue R, Potvin S, Bah R, Stip E, Bouchard RH, Lipp O, Gendron A, Kouassi E.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1695-8. doi: 10.1016/j.pnpbp.2011.05.011. Epub 2011 May 24.

PMID:
21627977
Items per page

Supplemental Content

Write to the Help Desk